Expression and significance of tripartite motif family proteins in hepatocellular carcinom

doi:10.3760/cma.j.issn.1673-422X.2018.06.014

Abstract

Abstract: Tripartite motif (TRIM) family, a very important protein family, has various functions in cellular biological processes including intracellular signal transduction, cell growth and apoptosis, innate immunity, autophagy and tumorigenesis. The specific expressions of TRIM in hepatocellular carcinoma are proved by many researches, which are closely related to the occurrence, metastasis and prognosis of hepatocellular carcinoma. TRIM are expected to be markers for the occurrence and development of hepatocellular carcinoma, and have broad prospects in the early diagnosis, therapy and prognosis of hepatocellular carcinoma.

Key words: Carcinoma, hepatocellular, Tripartite motif family

Li Meng, He De. Expression and significance of tripartite motif family proteins in hepatocellular carcinom[J]. Journal of International Oncology, 2018, 45(6): 375-378.

References

［1］ Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis［J］. Trends Biochem Sci, 2017, 42(4): 297-311. DOI: 10.1016/j.tibs.2017.01.002. ［2］ Esposito D, Koliopoulos MG, Rittinger K. Structural determinants of TRIM protein function［J］. Biochem Soc Trans, 2017, 45(1): 183-191. DOI: 10.1042/BST20160325. ［3］ Zhang Z, Xu C, Zhang X, et al. TRIM11 upregulation contributes to proliferation, invasion, and EMT of hepatocellular carcinoma cells［J］. Oncol Res, 2017, 25(5): 691-699. DOI: 10.3727/096504016X14774897404770. ［4］ Zhou Z, Liu Y, Ma M, et al. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/βcatenin signaling pathway［J］. Biomed Pharmacother, 2017, 96: 98-103. DOI: 10.1016/j.biopha.2017.09.132. ［5］ Kang KJ, Ahn KS. Anatomical resection of hepatocellular carcinoma: a critical review of the procedure and its benefits on survival［J］. World J Gastroenterol, 2017, 23(7): 1139-1146. DOI: 10.3748/wjg.v23.i7.1139. ［6］ Erstad DJ, Tanabe KK. Hepatocellular carcinoma: earlystage management challenges［J］. J Hepatocell Carcinoma, 2017, 4: 81-92. DOI: 10.2147/JHC.S107370. ［7］ Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis［J］. J Carcinog, 2017, 16: 1. DOI: 10.4103/jcar.JCar_9_16. ［8］ Chao J, Zhang XF, Pan QZ, et al. Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma［J］. Med Oncol, 2014, 31(8): 102. DOI: 10.1007/s12032-014-0102-9. ［9］ Huang XQ, Zhang XF, Xia JH, et al. Tripartite motifcontaining 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer［J］. Chin J Cancer, 2017, 36(1): 77. DOI: 10.1186/s40880-017-0240-5. ［10］ Chen Y, Li L, Qian X, et al. High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma［J］. Clin Res Hepatol Gastroenterol, 2017, 41(2): 190-196. DOI: 10.1016/j.clinre.2016.09.010. ［11］ Li L, Dong L, Qu X, et al. Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion［J］. Int J Oncol, 2016, 48(4): 1639-1649. DOI: 10.3892/ijo.2016.3398. ［12］Ding Q, He D, He K, et al. Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers［J］. Tumour Biol, 2015, 36(11): 8761-8772. DOI: 10.1007/s13277-015-3572-2. ［13］ Liu X, Huang Y, Yang D, et al. Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinoma［J］. PLoS One, 2014, 9(1): e85462. DOI: 10.1371/journal.pone.0085462. ［14］ Jiang S, Minter LC, Stratton SA, et al. TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice［J］. J Hepatol, 2015, 62(2): 371-379. DOI: 10.1016/j.jhep.2014.09.026. ［15］ Wang Y, He D, Yang L, et al. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis［J］. Biochem Biophys Res Commun, 2015, 463(3): 458-465. DOI: 10.1016/j.bbrc.2015.05.117. ［16］ Wang Y, Jiang J, Li Q, et al. KAP1 is overexpressed in hepatocellular carcinoma and its clinical significance［J］. Int J Clin Oncol, 2016, 21(5): 927-933. DOI: 10.1007/s10147016-0979-8. ［17］ Jin X, Pan Y, Wang L, et al. MAGETRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation［J］. Oncogenesis, 2017, 6(4): e312. DOI: 10.1038/oncsis.2017.21. ［18］ Cassano M, Offner S, Planet E, et al. Polyphenic trait promotes liver cancer in a model of epigenetic instability in mice［J］. Hepatology, 2017, 66(1): 235-251. DOI: 10.1002/hep.29182. ［19］ Guo P, Ma X, Zhao W, et al. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex［J］. Oncogene, 2018, 37(4): 478488. DOI: 10.1038/onc.2017.349. ［20］ Liu J, Zhang C, Wang XL, et al. E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis［J］. Cell Death Differ, 2014, 21(11): 1792-1804. DOI: 10.1038/cdd.2014.121. ［21］ Cui X, Lin Z, Chen Y, et al. Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinoma［J］. Mol Cell Biochem, 2016, 421(1-2): 127137. DOI: 10.1007/s11010-016-2793-z. ［22］ Chen Z, Lu X, Wang Z, et al. Coexpression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma［J］. Oncotarget, 2015, 6(4): 2538-2548. DOI: 10.18632/oncotarget.2991. ［23］ Chen Z, Wang Z, Guo W, et al. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma［J］. Oncogene, 2015, 34(30): 3946-3956. DOI: 10.1038/onc.2014.325. ［24］ Song L, Zhang W, Chang Z, et al. miR4417 targets tripartite motifcontaining 35 (TRIM35) and regulates pyruvate kinase muscle 2 (PKM2) phosphorylation to promote proliferation and suppress apoptosis in hepatocellular carcinoma cells［J］. Med Sci Monit, 2017, 23: 1741-1750. DOI: 10.12659/MSM.900296. ［25］ Jiang J, Yu C, Chen M, et al. Overexpression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt/betacatenin signaling［J］. Biochem Biophys Res Commun, 2015, 464(4): 1120-1127. DOI: 10.1016/j.bbrc.2015.07.089. ［26］ Zhu X, Wu Y, Miao X, et al. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma［J］. Tumour Biol, 2016, 37(11): 14615-14628. DOI: 10.1007/s1327701653163. ［27］ Zhang Y, Wu SS, Chen XH, et al. Tripartite motif containing 52 (TRIM52) promotes cell proliferation in Hepatitis B virusassociated hepatocellular carcinoma［J］. Med Sci Monit, 2017, 23: 5202-5210. ［28］ Qiu X, Huang Y, Zhou Y, et al. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication［J］. Oncol Rep, 2016, 36(2): 811-818. DOI: 10.3892/or.2016.4871. ［29］ Yang YF, Zhang MF, Tian QH, et al. TRIM65 triggers βcatenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma［J］. J Cell Sci, 2017, 130(18): 3108-3115. DOI: 10.1242/jcs.206623.